Xamamina 50 mg - 6 Capsuls

Xamamina 50 mg

Xamamina is a soft capsule drug containing dimenhydrate.

Therapeutic indications

What is Xamamina and what is it used for?

Xamamina is a medicine used to treat phenomena such as sea, plane, car and train sickness and therefore belongs to the category of anti-emetic (against vomiting) and anti-nausea drugs.

Dosage and Posology

How to use Xamamina?

In adults, administer 1 soft capsule of Xamamina half an hour before travel; if necessary, repeat the dose after 3-4 hours, up to a maximum of 4 soft capsules in 24 hours.

How to use

The Xamamina soft capsule should not be chewed, but swallowed even without water.

Overdose

What to do if you take too much Xamamina?

In case of accidental ingestion / intake of an overdose of Xamamine, notify your doctor immediately or go to the nearest hospital. The most common symptom of overdose is sleepiness. Toxic doses can cause seizures, coma and breathing problems.

Contraindications

When not to use Xamamina?

Hypersensitivity to the active substance, to other antihistamines or to any of the excipients.

Contraindicated in children under 2 years of age.

Contraindicated during pregnancy and breastfeeding

Side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Sedation, drowsiness, dry mouth, sensitivity to light, visual disturbances, impaired ability to urinate, headache, anorexia, nausea, allergic skin reactions may occur with the use of antihistamines. Less frequently: dizziness, feeling of weakness, insomnia (especially in children), euphoria, tremors, convulsions (especially in children), decreased blood pressure, increased heart rate.

Pregnancy and breastfeeding

Pregnancy

In reproduction studies in rats and rabbits, doses 20-25 times higher than those normally used in therapy in humans did not show teratogenic effects or reduced fertility. However, no data are available on the use of the product in pregnant women. Therefore, although the teratogenicity of the product appears unlikely, the use of dimenhydrinate in pregnancy is contraindicated.

Feeding time

Small amounts of dimenhydrinate pass into breast milk. Given the possible adverse events of the product in newborns, the use of dimenhydrinate during breastfeeding is

contraindicated.

Special warnings

What is important to know before taking Xamamina?

Xamamina should be administered with caution in subjects suffering from narrow-angle glaucoma, prostatic hypertrophy, urinary retention, slowed intestinal transit, bronchial asthma, epilepsy, porphyria. The product may mask the symptoms of ototoxicity and therefore should be administered with caution to patients receiving ototoxic drugs. Soft capsules and medicated chewing gums contain sorbitol: patients with rare hereditary problems of fructose intolerance should not take this medicine. The soft capsules contain parabens which can cause allergic reactions (including delayed ones).

Do not exceed the prescribed dose unless recommended by your physician.

Consult your doctor if the disorder occurs repeatedly or if you have noticed any recent changes in its characteristics.

Use only for short periods of treatment.

Expiry and retention

How to store Xamamina?

Xamamina must be stored at temperatures not exceeding 25 °.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition

What does Xamamina contain?

Xamamina contains, for each capsule:

Active principle

Dimenhydrinate 50 mg.

Excipients

macrogol 400; Wrapping: gelatin; partially dehydrated liquid sorbitol; ethyl sodium-parahydroxybenzoate (E215); propyl sodium parahydroxybenzoate (E 217).

Side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Sedation, drowsiness, dry mouth, sensitivity to light, visual disturbances, impaired ability to urinate, headache, anorexia, nausea, allergic skin reactions may occur with the use of antihistamines. Less frequently: dizziness, feeling of weakness, insomnia (especially in children), euphoria, tremors, convulsions (especially in children), decreased blood pressure, increased heart rate.

Pregnancy and breastfeeding

Pregnancy

In reproduction studies in rats and rabbits, doses 20-25 times higher than those normally used in therapy in humans did not show teratogenic effects or reduced fertility. However, no data are available on the use of the product in pregnant women. Therefore, although the teratogenicity of the product appears unlikely, the use of dimenhydrinate in pregnancy is contraindicated.

Feeding time

Small amounts of dimenhydrinate pass into breast milk. Given the possible adverse events of the product in newborns, the use of dimenhydrinate during breastfeeding is

contraindicated.

Special warnings

What is important to know before taking Xamamina?

Xamamina should be administered with caution in subjects suffering from narrow-angle glaucoma, prostatic hypertrophy, urinary retention, slowed intestinal transit, bronchial asthma, epilepsy, porphyria. The product may mask the symptoms of ototoxicity and therefore should be administered with caution to patients receiving ototoxic drugs. Soft capsules and medicated chewing gums contain sorbitol: patients with rare hereditary problems of fructose intolerance should not take this medicine. The soft capsules contain parabens which can cause allergic reactions (including delayed ones).

Do not exceed the prescribed dose unless recommended by your physician.

Consult your doctor if the disorder occurs repeatedly or if you have noticed any recent changes in its characteristics.

Use only for short periods of treatment.

Expiry and retention

How to store Xamamina?

Xamamina must be stored at temperatures not exceeding 25 °.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition

What does Xamamina contain?

Xamamina contains, for each capsule:

Active principle

Dimenhydrinate 50 mg.

Excipients

macrogol 400; Wrapping: gelatin; partially dehydrated liquid sorbitol; ethyl sodium-parahydroxybenzoate (E215); propyl sodium parahydroxybenzoate (E 217).